Oak Ridge, TN, May 25, 2023 DAXOR CORPORATION , the global leader in blood volume measurement technology, today announced the closing of its previously announced underwritten public offering of. | May 25, 2023
22.05.2023 - Company also to provide a corporate overview in a separate session HANOVER, MD, May 22, 2023 (GLOBE NEWSWIRE) - Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company now focused on .
Oak Ridge, TN, May 19, 2023 DAXOR CORPORATION , the global leader in blood volume measurement technology, today announces that it has commenced an underwritten public offering of shares of its. | May 19, 2023
Executing commercial strategy for elite Camelina in the biofuels marketMet target for 2023 contracted spring Camelina acresPermitting complete, planting underway for spring seed scale-up and field testing
Executing commercial strategy for elite Camelina in the biofuels market Met target for 2023 contracted spring Camelina acres Permitting complete, planting…